Table 1: The demographic and clinical characteristics of each SLE patient with AP.

CaseAge at SLE onset (y)Duration between onset of SLE and AP (m)SLEDAI score at onset of APNumber of involved organs concomitant with APGC treatment after onset of APOutcome

1230.595Increased doseIn remission
21648124StopIn remission
31812146Increased doseDied
42272147Increased doseIn remission
51636167Increased doseIn remission
65724174Increased doseIn remission
7360.5176Initial treatmentDied
848180187maintainingDied
91436214maintainingDied
101412237Increased doseDied
11192236Increased doseIn remission
12142277Increased doseDied
13461254Increased doseIn remission
14220.25183Decreased doseIn remission
1551240186Decreased doseIn remission
16424197Increased doseIn remission
172084185Decreased doseDied
183924135Increased doseIn remission
19152336Decreased doseDied
201536417Increased doseIn remission
21263418Increased doseDied
22391276Increased doseIn remission
232072103maintainingIn remission
243612386maintainingDied
2516283Increased doseIn remission
263048478Increased doseIn remission
271472196maintainingIn remission